Grade Increases in Gastroenteropancreatic Neuroendocrine Tumor Metastases Compared to the Primary Tumor

Publisher： Karger

E-ISSN： 1423-0194|103|5|452-459

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.103, Iss.5, 2015-08, pp. : 452-459

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is There an Additional Value of Using Somatostatin Receptor Subtype 2a Immunohistochemistry Compared to Somatostatin Receptor Scintigraphy Uptake in Predicting Gastroenteropancreatic Neuroendocrine Tumor Response?

By  

Neuroendocrinology, Vol. 103, Iss. 5, 2015-11 ,pp. : 560-566

Karger

Access to resources Recommend Favorite

Nuclear Survivin Is a Powerful Novel Prognostic Marker in Gastroenteropancreatic Neuroendocrine Tumor Disease

By  

Neuroendocrinology, Vol. 81, Iss. 1, 2005-05 ,pp. : 1-9

Karger

Access to resources Recommend Favorite

From Basic to Clinical Research in Gastroenteropancreatic Neuroendocrine Tumor Disease – The Clinician-Scientist Perspective

By  

Neuroendocrinology, Vol. 80, Iss. 1, 2004-10 ,pp. : 94-98

Karger

Access to resources Recommend Favorite

Inhibition of mTOR's Catalytic Site by PKI-587 Is a Promising Therapeutic Option for Gastroenteropancreatic Neuroendocrine Tumor Disease

By  

Neuroendocrinology, Vol. 105, Iss. 1, 2016-08 ,pp. : 90-104

Karger

Access to resources Recommend Favorite

ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas

By  

Neuroendocrinology, Vol. 103, Iss. 2, 2016-01 ,pp. : 186-194

Karger

Access to resources Recommend Favorite